EvoGenix – Integrating advanced technologies to provide powerful new antibody therapeutics for world markets. EvoGenix applies its proprietary antibody engineering platforms for humanisation, and optimisation to develop highly potent therapeutic antibodies against validated drug targets.

Peptech & EvoGenix have now merged. Please click on the link below to connect to Peptech >>>

EvoGenix & PEPTECH Merger

SCHEME BOOKLET download

Additional Merger Information

Court approves merger

EGX Shareholders Approve Merger

EGX Results of Scheme Meeting